Skip to main content
. 2021 Jul 22;12:714943. doi: 10.3389/fimmu.2021.714943

Figure 2.

Figure 2

Rux treatment decreased the number of NLRP3+ and CD68+ cells in the ischemic penumbra. (A) Representative images of NLRP3 and CD68 immunostaining in the ischemic penumbra of sham-, vehicle-, Rux- and MCC950-treated mice 3 days after stroke. (B, C) Statistical analysis of NLRP3+ and CD68+ cells. (D) Quantification of double-positive cells in the peri-ischemic region. Means ± SD. n = 5. aP < 0.01 versus sham; bP < 0.01 versus vehicle. Scale bar: 50 µm.